F19.21
Other psychoactive substance dependence, in remission
Clinical Classification Guidelines
Inclusion Terms
- Other (or unknown) substance use disorder, moderate, in early remission
- Other (or unknown) substance use disorder, moderate, in sustained remission
- Other (or unknown) substance use disorder, severe, in early remission
- Other (or unknown) substance use disorder, severe, in sustained remission
Medical Intelligence & Overview
ICD-10 code F19.21 refers to a condition where an individual had developed dependence on a psychoactive substance but is currently not showing active symptoms. This state is known as remission, which can be either early or sustained. Understanding this condition involves recognizing its causes, symptoms, how it's diagnosed, and potential treatment options.
Causes & Symptoms
Clinical Causes: Chronic use of psychoactive substances over an extended period Development of physical and psychological dependence Underlying mental health conditions that may contribute to substance use Environmental factors, such as peer pressure or stressful life events Genetic predispositions affecting susceptibility to substance dependence
Key Symptoms: Previous compulsive drug-seeking behaviors Persistent cravings for the substance Lower tolerance to stress without substance use Periods of abstinence with minimal or no immediate withdrawal symptoms Possible mood changes or feelings of depression during remission
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a comprehensive assessment by healthcare professionals, including medical history, substance use patterns, and psychological evaluation. Specific criteria from the ICD-10 guide clinicians to identify whether the dependence is moderate or severe and at what stage of remission the individual is in. laboratory tests or specialized screening tools may also be used to confirm past substance use and current remission status.
Treatment Protocols: While someone is in remission, ongoing support is essential to prevent relapse and maintain recovery. Treatment strategies may include:
Clinical Advice & FAQs
Billing Guidance
Is F19.21 a billable ICD-10 code?
Yes, F19.21 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F19.21?
Clinical documentation must specify the nature of Other psychoactive substance dependence, in remission and any associated comorbidities for accurate reporting.
Cite this Clinical Reference